ACHE and Alzheimer disease: Below we describe a study with a secondary aim of understanding the role of drug-drug interactions and pharmacogenomics in patients receiving therapy as routinely provided to AD patients to better understand the reasons for adherence and persistence to acetylcholinesterase inhibitors (ChEIs).